• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ENDOLOGIX SANTA ROSA OVATION IX; ILIAC LIMB

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ENDOLOGIX SANTA ROSA OVATION IX; ILIAC LIMB Back to Search Results
Model Number TV-IL1412120-J
Medical Device Problem Codes Complete Blockage (1094); Insufficient Device Problem Information (3190)
Health Effect - Clinical Codes Failure of Implant (1924); Obstruction/Occlusion (2422)
Date of Event 10/07/2021
Type of Reportable Event Serious Injury
Additional Manufacturer Narrative
The devices involved in this event will not be returned for evaluation and remain implanted in the patient.Patient medical records and imaging studies will be requested for further evaluation by a clinical specialist.If additional information pertinent to the incident is obtained, a follow-up report will be submitted.
 
Event or Problem Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with the ovation ix abdominal aortic aneurysm stent graft system.Approximately three (3) years post initial procedure limb occlusion was identified.Reintervention was completed by declotting the limb and implanting an additional ovation ix iliac limb.There was also proximal stenosis that was ballooned using a 10 x 4 pta balloon.The patient was reported to be doing well.
 
Event or Problem Description
The patient was initially treated for an abdominal aortic aneurysm (aaa) with the ovation ix abdominal aortic aneurysm stent graft system.Approximately three (3) years post initial procedure limb occlusion was identified.Reintervention was completed by declotting the limb and implanting an additional ovation ix iliac limb.There was also proximal stenosis that was ballooned using a 10x4 pta balloon.The patient was reported to be doing well.Additional information: an internal clinical assessment determined that there was evidence to reasonably suggest a type 2 endoleak (non-device related) of the lumbar artery occurred that was not included in the event as reported.The type 2 endoleak was discovered during review of the 1 month post implant ct scan.
 
Additional Manufacturer Narrative
The reported adverse event/incident was investigated in alignment with endologix operating procedures and work instructions.Where possible, it is endologix practice to make at least three good faith efforts to retrieve a reported adverse event/incident related device as well as medical records and medical imaging.An evaluation of the manufacturing record was completed.A review of the part number/lot number combination needed for device identification shows the device to have been properly manufactured and released in accordance with the device master record.The review confirms there were no manufacturing or processing non-conformities identified that would contribute to the reported adverse event/incident.An evaluation of the device could not be completed.The device was not returned to endologix for evaluation because it remains implanted.A clinical evaluation of the adverse event/incident was completed.An examination of medical records and/or medical imaging received by endologix shows that the right iliac limb occlusion is confirmed from the medical records.This is consistent with the reported adverse event/incident.The clinical evaluation also shows reasonable evidence to suggest a type 2 endoleak of the lumbar artery occurred that was not included in the event as reported.There was a total occlusion of the proximal right common iliac artery at the index procedure.It is unclear if this contributed to the reported event.There were thickened calcifications in the iliac arteries (cautionary product use condition).Procedure related harms, device, user, procedure or anatomy relatedness of this complaint could not be determined with the medical records available for review.The final patient status was reported to be doing well.No additional investigation of this reported adverse event/incident is planned.However, should additional information relevant to the investigation outcome become available, a follow-up report will be submitted.Endologix will continue to monitor this and similar adverse events/incidents.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OVATION IX
Common Device Name
ILIAC LIMB
Manufacturer (Section D)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
santa rosa CA 95403
Manufacturer (Section G)
ENDOLOGIX SANTA ROSA
3910 brickway blvd
,
santa rosa CA 95403
Manufacturer Contact
gary kirchgater
3910 brickway blvd
,
santa rosa, CA 95403
8009832284
MDR Report Key12674762
Report Number3008011247-2021-00125
Device Sequence Number3750176
Product Code MIH
UDI-Device IdentifierM701TVIL1412120J1
UDI-Public+M701TVIL1412120J1/$$3201130FS101917138
Combination Product (Y/N)N
Initial Reporter StateMO
Initial Reporter CountryUS
PMA/510(K) Number
P120006
Number of Events Summarized1
Summary Report (Y/N)N
Device Implanted Year2018
Reporter Type Manufacturer
Report Source Other,Health Professional,Company Representative
Initial Reporter Occupation Physician
Remedial Action Other
Type of Report Initial,Followup
Report Date (Section B) 10/07/2021
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Operator of Device Health Professional
Device Expiration Date11/30/2020
Device Model NumberTV-IL1412120-J
Device Catalogue NumberTV-IL1412120-J
Device Lot NumberFS101917-13
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 10/07/2021
Supplement Date Received by Manufacturer11/30/2021
Initial Report FDA Received Date10/21/2021
Supplement Report FDA Received Date12/16/2021
Was Device Evaluated by Manufacturer? (Y/N) Device Not Returned to Manufacturer
Date Device Manufactured12/21/2017
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Concomitant Medical Products
and Therapy/Usage Dates
OVATION IX ILIAC LIMB (LN FS032818-71); OVATION IX MAIN BODY (LN FS042018-10); OVATION PRIME FILL POLYMER (LN FF022818-01); OVATION PRIME FILL POLYMER (LN FF042518-01); OVATION IX ILIAC LIMB (LN FS032818-71); OVATION IX MAIN BODY (LN FS042018-10); OVATION PRIME FILL POLYMER (LN FF022818-01); OVATION PRIME FILL POLYMER (LN FF042518-01)
Outcome Attributed to Adverse Event Required Intervention;
Patient Age69 YR
Patient SexFemale
-
-